W
TEVA icon

Wealthfront’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Wealthfront’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-167
Closed -$9K – 967
2015
Q3 		$9K Buy
+167
New +$10.8K ﹤0.01% 993

Other funds holding TEVA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

Wealthfront's TEVA Position: Q4 2015 in Review

Wealthfront sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q4 2015, closing a stake of 167 shares — an estimated $9K sold.

Wealthfront first reported a position in TEVA in Q3 2015 and held it in 1 quarter. The position peaked at $9K in Q3 2015. 877 funds tracked by Wall St. Rank hold TEVA as of Q4 2015.

  • Wealthfront reported no remaining Teva Pharmaceutical Industries Limited position as of Q4 2015 after selling out during the quarter.
  • Wealthfront sold 167 Teva Pharmaceutical Industries Limited shares in Q4 2015, an estimated $9K.
  • Wealthfront first reported a position in Teva Pharmaceutical Industries Limited in Q3 2015 and held it in 1 quarter.
  • Wealthfront's Teva Pharmaceutical Industries Limited position peaked at $9K in Q3 2015.
  • 877 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q4 2015.

Based on Wealthfront's 13F filing for Q4 2015, filed 17 Feb 2016.